Literature DB >> 11748945

Contaminants from the transplant contribute to intimal hyperplasia associated with microvascular endothelial cell seeding.

C H P Arts1, P Ph A Hedeman Joosten, J D Blankensteijn, F J T Staal, P Y Y Ng, G J Heijnen-Snyder, J J Sixma, H J M Verhagen, P G de Groot, B C Eikelboom.   

Abstract

OBJECTIVES: seeding prosthetic grafts with fat-derived microvascular endothelial cells (MVEC) results not only in a non-thrombogenic EC layer, but also in intimal hyperplasia. Here we investigated incidence, composition, progression, and cause of this intimal hyperplasia.
DESIGN: EPTFE grafts with MVEC were implanted as carotid interpositions in six dogs with 1 month, and in three dogs with 4, 8 and 12 months follow-up. Grafts seeded without cells, implanted in the contralateral carotid, served as a control. In another three dogs labelled cells were seeded to investigate the contribution of the seeded cells (2-3 weeks).
MATERIALS AND METHODS: MVEC were isolated from the falciform ligament. Cells were pressure seeded on ePTFE grafts. Labelling was performed using retroviral gene transduction. The grafts were analysed with immunohistochemical techniques.
RESULTS: after 1 month, all patent non-seeded grafts (5/6) showed fibrin and platelet deposition, and all patent seeded grafts (5/6) were covered with a confluent endothelial monolayer on top of a multilayer of myofibroblasts, elastin and collagen. After long term follow-up, all non-seeded grafts were occluded, all patent seeded grafts (4 and 12 months) were covered with an EC-layer with intimal hyperplasia underneath. The thickness of the intima did not progress after 1 month. Transduced cells were found in the endothelial monolayer, hyperplastic intima and luminal part of the prosthesis.
CONCLUSIONS: MVEC seeding in dogs results in intimal hyperplasia in all patent grafts, which contains myofibroblasts. Contaminants from the transplant contribute to this intimal hyperplasia. Copyright 2002 Harcourt Publishers Limited.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11748945     DOI: 10.1053/ejvs.2001.1532

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  8 in total

1.  Endothelial Cell Vascular Smooth Muscle Cell Co-Culture Assay For High Throughput Screening Assays For Discovery of Anti-Angiogenesis Agents and Other Therapeutic Molecules.

Authors:  George A Truskey
Journal:  Int J High Throughput Screen       Date:  2010-10-01

2.  Evaluation of late outgrowth endothelial progenitor cell and umbilical vein endothelial cell responses to thromboresistant collagen-mimetic hydrogels.

Authors:  Dany J Munoz-Pinto; Josh D Erndt-Marino; Silvia M Becerra-Bayona; Viviana R Guiza-Arguello; Satyavrata Samavedi; Sarah Malmut; William M Reichert; Brooke Russell; Magnus Höök; Mariah S Hahn
Journal:  J Biomed Mater Res A       Date:  2017-03-29       Impact factor: 4.396

3.  Comparison of endothelial cell- and endothelial progenitor cell-derived exosomes in promoting vascular endothelial cell repair.

Authors:  Hui Hu; Chunyu Jiang; Ruiting Li; Jungong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

4.  Biological and engineering design considerations for vascular tissue engineered blood vessels (TEBVs).

Authors:  Cristina E Fernandez; Hardean E Achneck; William M Reichert; George A Truskey
Journal:  Curr Opin Chem Eng       Date:  2014-02-01       Impact factor: 5.163

5.  Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers.

Authors:  John D Stroncek; Bryan S Grant; Melissa A Brown; Thomas J Povsic; George A Truskey; William M Reichert
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

6.  Concise Review: Patency of Small-Diameter Tissue-Engineered Vascular Grafts: A Meta-Analysis of Preclinical Trials.

Authors:  Ida Skovrind; Eva Bang Harvald; Helene Juul Belling; Christian Damsgaard Jørgensen; Jes Sanddal Lindholt; Ditte Caroline Andersen
Journal:  Stem Cells Transl Med       Date:  2019-03-28       Impact factor: 6.940

Review 7.  Failure Analysis of TEVG's I: Overcoming the Initial Stages of Blood Material Interaction and Stabilization of the Immune Response.

Authors:  Maria A Rodriguez-Soto; Natalia Suarez Vargas; Alejandra Riveros; Carolina Muñoz Camargo; Juan C Cruz; Nestor Sandoval; Juan C Briceño
Journal:  Cells       Date:  2021-11-12       Impact factor: 6.600

Review 8.  Review: Tissue Engineering of Small-Diameter Vascular Grafts and Their In Vivo Evaluation in Large Animals and Humans.

Authors:  Shu Fang; Ditte Gry Ellman; Ditte Caroline Andersen
Journal:  Cells       Date:  2021-03-23       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.